You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

Incruse and Relvar Ellipta pack shot

Relvar Ellipta in combination with Incruse Ellipta - a straightforward option[1] for your COPD patients suitable for a LAMA in combination with ICS/LABA.

Reference:

  1. Incruse Ellipta 55 mcg SmPC; GlaxoSmithKline.
Innoviva logo

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard.
Adverse events should also be reported to GlaxoSmithKline UK on 0800 221 441.

Incruse, Relvar and Ellipta are registered trademarks of the GlaxoSmithKline group of companies.